733 related articles for article (PubMed ID: 24187469)
1. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
2. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
3. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Yang R; Shang J; Zhou Y; Liu W; Tian Y; Shang H
Expert Rev Gastroenterol Hepatol; 2021 Dec; 15(12):1401-1409. PubMed ID: 34877910
[TBL] [Abstract][Full Text] [Related]
4. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Loman BR; Hernández-Saavedra D; An R; Rector RS
Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
[TBL] [Abstract][Full Text] [Related]
5. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
[TBL] [Abstract][Full Text] [Related]
6. The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.
Wang Y; Wang Y; Sun J
Bioengineered; 2022; 13(7-12):14960-14973. PubMed ID: 37105767
[TBL] [Abstract][Full Text] [Related]
7. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
[TBL] [Abstract][Full Text] [Related]
8. Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease.
Huang Y; Wang X; Zhang L; Zheng K; Xiong J; Li J; Cong C; Gong Z; Mao J
Comput Math Methods Med; 2022; 2022():7888076. PubMed ID: 35677177
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Liu L; Li P; Liu Y; Zhang Y
Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
[TBL] [Abstract][Full Text] [Related]
10. Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.
Xiong Y; Peng Q; Cao C; Xu Z; Zhang B
Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33801028
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis.
Zou TT; Zhang C; Zhou YF; Han YJ; Xiong JJ; Wu XX; Chen YP; Zheng MH
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):747-755. PubMed ID: 29683979
[TBL] [Abstract][Full Text] [Related]
12. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
Front Nutr; 2022; 9():880014. PubMed ID: 35669067
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease.
Xiao MW; Lin SX; Shen ZH; Luo WW; Wang XY
Gastroenterol Res Pract; 2019; 2019():1484598. PubMed ID: 31885541
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
[TBL] [Abstract][Full Text] [Related]
15. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
16. Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis.
Dai Y; Quan J; Xiong L; Luo Y; Yi B
Ren Fail; 2022 Dec; 44(1):862-880. PubMed ID: 35611435
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
18. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
19. Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.
Du J; Ma YY; Yu CH; Li YM
World J Gastroenterol; 2014 Jan; 20(2):569-77. PubMed ID: 24574727
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis.
Hu H; Wang J; Li X; Shen L; Shi D; Meng J
Curr Pharm Des; 2021; 27(29):3235-3243. PubMed ID: 33719959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]